Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML)
2015-002281-23Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tefinostat in chronic myelomonocytic leukemia (CMML), sponsored by Cardiff University. Primary endpoint: Safety and tolerability. Started Apr 2016; status: completed.
02
Drugs
tefinostat
03
Conditions
chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on 2015-002281-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002281-23.